Polar Capital Funds PLC - Biotechnology Fund R Inc (EUR)Register to Unlock Ratings |
Performance History | 31/07/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | 35.9 | 5.2 | 4.2 | 9.1 | 11.6 |
![]() | +/-Cat | 9.9 | 14.2 | 12.0 | 10.4 | 7.9 |
![]() | +/-B’mrk | 3.0 | 4.9 | 1.7 | 1.8 | -4.8 |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: Morningstar Gbl Biotechnolo... |
Key Stats | ||
NAV 13/08/2024 | EUR 42.10 | |
Day Change | 0.99% | |
Morningstar Category™ | Sector Equity Biotechnology | |
ISIN | IE00B3VXGD32 | |
Fund Size (Mil) 13/08/2024 | USD 1863.84 | |
Share Class Size (Mil) 13/08/2024 | USD 678.44 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 30/06/2024 | 1.62% |
Investment Objective: Polar Capital Funds PLC - Biotechnology Fund R Inc (EUR) |
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Pinniger 31/10/2013 | ||
Gareth Powell 31/10/2013 | ||
Inception Date 31/10/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
NASDAQ Biotechnology NR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Polar Capital Funds PLC - Biotechnology Fund R Inc (EUR) | 30/06/2024 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 7.05 |
![]() | ![]() | 5.56 |
![]() | ![]() | 5.43 |
![]() | ![]() | 5.02 |
![]() | ![]() | 4.63 |
![]() | ||
![]() ![]() ![]() | ||
Polar Capital Funds PLC - Biotechnology Fund R Inc (EUR) |